In the present study we compared TIL content in paired primary and metastatic tumors from RCC patients with stage IV disease and examined the associations with clinicopathologic tumor characteristics and corresponding levels of tumor PD-L1 expression. The gene discussed is CD274; the disease is renal cell carcinoma.